Shopping Cart 0
Cart Subtotal
AED 0

Exalenz Bioscience Ltd (EXEN) - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 8258

Details

Summary

Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional disorders. Its flagship product, BreathID Hp is a US FDA approved and European CE marked urea breath test for diagnosing, monitoring and managing gastric Helicobacter pylori (H. pylori) infection in adults as well as pediatric and tests patients of 3 to 17 years of age. It offers BreathID Gastro used for the diagnosis of liver and GI disorders. It also offers BreathID 13C-methacetin breath test, a non-invasive point of care tool measures the microsomal function of the liver. Exalenz is headquartered in Modiin, Israel.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Exalenz Bioscience Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Exalenz Bioscience Ltd Company Overview

Exalenz Bioscience Ltd Company Snapshot

Exalenz Bioscience Ltd Pipeline Products and Ongoing Clinical Trials Overview

Exalenz Bioscience Ltd-Pipeline Analysis Overview

Business Description

Exalenz Bioscience Ltd-Key Facts

Exalenz Bioscience Ltd-Major Products and Services

Exalenz Bioscience Ltd Pipeline Products by Development Stage

Exalenz Bioscience Ltd Ongoing Clinical Trials by Trial Status

Exalenz Bioscience Ltd Pipeline Products Overview

BreathID Methacetin Breath Test-Acute Liver Failure

BreathID Methacetin Breath Test-Acute Liver Failure Product Overview

BreathID Methacetin Breath Test-Acute Liver Failure Clinical Trial

BreathID Methacetin Breath Test-NASH

BreathID Methacetin Breath Test-NASH Product Overview

BreathID Methacetin Breath Test-NASH Clinical Trial

BreathID Test-Chronic Liver Disease

BreathID Test-Chronic Liver Disease Product Overview

BreathID Test-Chronic Liver Disease Clinical Trial

BreathID Test-Hepatocellular Carcinoma

BreathID Test-Hepatocellular Carcinoma Product Overview

BreathID Test-Pancreatitis

BreathID Test-Pancreatitis Product Overview

BreathID Test-Portal Hypertension

BreathID Test-Portal Hypertension Product Overview

Exalenz Bioscience Ltd-Key Competitors

Exalenz Bioscience Ltd-Key Employees

Exalenz Bioscience Ltd-Key Employee Biographies

Exalenz Bioscience Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Exalenz Bioscience Ltd, Recent Developments

Feb 25, 2019: Exalenz Bioscience receives approval for commercial marketing in China for Its BreathID Hp Lab System

Nov 04, 2018: Data collected by Exalenz Bioscience in Galectin Therapeutics phase 2 NASH-CX trial of GR-MD-02 to be presented at AASLD Annual Meeting

Aug 31, 2018: Exalenz Bioscience announces second quarter 2018 financial results

Jul 10, 2018: Exalenz Bioscience's Non-Invasive BreathID Test to be Evaluated in Two Bristol-Myers Squibb Phase 2b Clinical Trials in Adult Patients with NASH

Apr 30, 2018: Exalenz Bioscience Appoints Roy Golan as President and Chief Financial Officer

Mar 13, 2018: Exalenz Bioscience's BreathID Hp & BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients

Mar 12, 2018: Exalenz Announces Fourth Quarter and Full Year 2017 Financial Results

Jan 30, 2018: Carestream's Vue Motion Universal Viewer Earns 2018 KLAS Category Leader Award

Jan 23, 2018: Exalenz Bioscience Announces Positive Clinical Trial Results for the Diagnosis of Clinically Significant Portal Hypertension in NASH Patients

Jan 01, 2018: A New Perspective on MR with Philips

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Exalenz Bioscience Ltd Pipeline Products by Equipment Type

Exalenz Bioscience Ltd Pipeline Products by Development Stage

Exalenz Bioscience Ltd Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Exalenz Bioscience Ltd Pipeline Products and Ongoing Clinical Trials Overview

Exalenz Bioscience Ltd Pipeline Products by Equipment Type

Exalenz Bioscience Ltd Pipeline Products by Indication

Exalenz Bioscience Ltd Ongoing Clinical Trials by Trial Status

Exalenz Bioscience Ltd, Key Facts

Exalenz Bioscience Ltd, Major Products and Services

Exalenz Bioscience Ltd Number of Pipeline Products by Development Stage

Exalenz Bioscience Ltd Pipeline Products Summary by Development Stage

Exalenz Bioscience Ltd Ongoing Clinical Trials by Trial Status

Exalenz Bioscience Ltd Ongoing Clinical Trials Summary

BreathID Methacetin Breath Test-Acute Liver Failure-Product Status

BreathID Methacetin Breath Test-Acute Liver Failure-Product Description

BreathID Methacetin Breath Test-Acute Liver Failure-13C-Methacetin Breath Test for the Prediction of Outcome in Acute Liver Failure

BreathID Methacetin Breath Test-Acute Liver Failure-A Multi-center Trial to Study Acute Liver Failure in Adults

BreathID Methacetin Breath Test-NASH-Product Status

BreathID Methacetin Breath Test-NASH-Product Description

BreathID Methacetin Breath Test-NASH-A Phase IIb Randomized Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in Adults with Nonalcoholic Steatohepatitis (NASH) and Stage III Liver Fibrosis

BreathID Methacetin Breath Test-NASH-A Phase IIB Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in Adults with Nonalcoholic Steatohepatitis (NASH) and Compensated Liver Cirrhosis

BreathID Methacetin Breath Test-NASH-Study on Clinical Utility of BreathID in Diagnosis of Nonalcoholic Steatohepatitis

BreathID Test-Chronic Liver Disease-Product Status

BreathID Test-Chronic Liver Disease-Product Description

BreathID Test-Chronic Liver Disease-13C-Methacetin Breath Test for the Prediction of Outcome in Acute Liver Failure

BreathID Test-Hepatocellular Carcinoma-Product Status

BreathID Test-Hepatocellular Carcinoma-Product Description

BreathID Test-Pancreatitis-Product Status

BreathID Test-Pancreatitis-Product Description

BreathID Test-Portal Hypertension-Product Status

BreathID Test-Portal Hypertension-Product Description

Exalenz Bioscience Ltd, Key Employees

Exalenz Bioscience Ltd, Key Employee Biographies

Exalenz Bioscience Ltd, Subsidiaries

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Exalenz Bioscience Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Serim Research Corporation

Meridian Bioscience Inc

MedMira Inc

Kibion AB

Company Profile

Company Profile Title

Summary

Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional disorders. Its flagship product, BreathID Hp is a US FDA approved and European CE marked urea breath test for diagnosing, monitoring and managing gastric Helicobacter pylori (H. pylori) infection in adults as well as pediatric and tests patients of 3 to 17 years of age. It offers BreathID Gastro used for the diagnosis of liver and GI disorders. It also offers BreathID 13C-methacetin breath test, a non-invasive point of care tool measures the microsomal function of the liver. Exalenz is headquartered in Modiin, Israel.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Exalenz Bioscience Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Exalenz Bioscience Ltd Company Overview

Exalenz Bioscience Ltd Company Snapshot

Exalenz Bioscience Ltd Pipeline Products and Ongoing Clinical Trials Overview

Exalenz Bioscience Ltd-Pipeline Analysis Overview

Business Description

Exalenz Bioscience Ltd-Key Facts

Exalenz Bioscience Ltd-Major Products and Services

Exalenz Bioscience Ltd Pipeline Products by Development Stage

Exalenz Bioscience Ltd Ongoing Clinical Trials by Trial Status

Exalenz Bioscience Ltd Pipeline Products Overview

BreathID Methacetin Breath Test-Acute Liver Failure

BreathID Methacetin Breath Test-Acute Liver Failure Product Overview

BreathID Methacetin Breath Test-Acute Liver Failure Clinical Trial

BreathID Methacetin Breath Test-NASH

BreathID Methacetin Breath Test-NASH Product Overview

BreathID Methacetin Breath Test-NASH Clinical Trial

BreathID Test-Chronic Liver Disease

BreathID Test-Chronic Liver Disease Product Overview

BreathID Test-Chronic Liver Disease Clinical Trial

BreathID Test-Hepatocellular Carcinoma

BreathID Test-Hepatocellular Carcinoma Product Overview

BreathID Test-Pancreatitis

BreathID Test-Pancreatitis Product Overview

BreathID Test-Portal Hypertension

BreathID Test-Portal Hypertension Product Overview

Exalenz Bioscience Ltd-Key Competitors

Exalenz Bioscience Ltd-Key Employees

Exalenz Bioscience Ltd-Key Employee Biographies

Exalenz Bioscience Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Exalenz Bioscience Ltd, Recent Developments

Feb 25, 2019: Exalenz Bioscience receives approval for commercial marketing in China for Its BreathID Hp Lab System

Nov 04, 2018: Data collected by Exalenz Bioscience in Galectin Therapeutics phase 2 NASH-CX trial of GR-MD-02 to be presented at AASLD Annual Meeting

Aug 31, 2018: Exalenz Bioscience announces second quarter 2018 financial results

Jul 10, 2018: Exalenz Bioscience's Non-Invasive BreathID Test to be Evaluated in Two Bristol-Myers Squibb Phase 2b Clinical Trials in Adult Patients with NASH

Apr 30, 2018: Exalenz Bioscience Appoints Roy Golan as President and Chief Financial Officer

Mar 13, 2018: Exalenz Bioscience's BreathID Hp & BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients

Mar 12, 2018: Exalenz Announces Fourth Quarter and Full Year 2017 Financial Results

Jan 30, 2018: Carestream's Vue Motion Universal Viewer Earns 2018 KLAS Category Leader Award

Jan 23, 2018: Exalenz Bioscience Announces Positive Clinical Trial Results for the Diagnosis of Clinically Significant Portal Hypertension in NASH Patients

Jan 01, 2018: A New Perspective on MR with Philips

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Exalenz Bioscience Ltd Pipeline Products by Equipment Type

Exalenz Bioscience Ltd Pipeline Products by Development Stage

Exalenz Bioscience Ltd Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Exalenz Bioscience Ltd Pipeline Products and Ongoing Clinical Trials Overview

Exalenz Bioscience Ltd Pipeline Products by Equipment Type

Exalenz Bioscience Ltd Pipeline Products by Indication

Exalenz Bioscience Ltd Ongoing Clinical Trials by Trial Status

Exalenz Bioscience Ltd, Key Facts

Exalenz Bioscience Ltd, Major Products and Services

Exalenz Bioscience Ltd Number of Pipeline Products by Development Stage

Exalenz Bioscience Ltd Pipeline Products Summary by Development Stage

Exalenz Bioscience Ltd Ongoing Clinical Trials by Trial Status

Exalenz Bioscience Ltd Ongoing Clinical Trials Summary

BreathID Methacetin Breath Test-Acute Liver Failure-Product Status

BreathID Methacetin Breath Test-Acute Liver Failure-Product Description

BreathID Methacetin Breath Test-Acute Liver Failure-13C-Methacetin Breath Test for the Prediction of Outcome in Acute Liver Failure

BreathID Methacetin Breath Test-Acute Liver Failure-A Multi-center Trial to Study Acute Liver Failure in Adults

BreathID Methacetin Breath Test-NASH-Product Status

BreathID Methacetin Breath Test-NASH-Product Description

BreathID Methacetin Breath Test-NASH-A Phase IIb Randomized Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in Adults with Nonalcoholic Steatohepatitis (NASH) and Stage III Liver Fibrosis

BreathID Methacetin Breath Test-NASH-A Phase IIB Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in Adults with Nonalcoholic Steatohepatitis (NASH) and Compensated Liver Cirrhosis

BreathID Methacetin Breath Test-NASH-Study on Clinical Utility of BreathID in Diagnosis of Nonalcoholic Steatohepatitis

BreathID Test-Chronic Liver Disease-Product Status

BreathID Test-Chronic Liver Disease-Product Description

BreathID Test-Chronic Liver Disease-13C-Methacetin Breath Test for the Prediction of Outcome in Acute Liver Failure

BreathID Test-Hepatocellular Carcinoma-Product Status

BreathID Test-Hepatocellular Carcinoma-Product Description

BreathID Test-Pancreatitis-Product Status

BreathID Test-Pancreatitis-Product Description

BreathID Test-Portal Hypertension-Product Status

BreathID Test-Portal Hypertension-Product Description

Exalenz Bioscience Ltd, Key Employees

Exalenz Bioscience Ltd, Key Employee Biographies

Exalenz Bioscience Ltd, Subsidiaries

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Exalenz Bioscience Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Serim Research Corporation

Meridian Bioscience Inc

MedMira Inc

Kibion AB